Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | HTR1A | P08908 | 2/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10693703 | 0.81 | GABRA1 (0.45) | GABRA1GABRB2ALDH1A1KDM4EHTR1A | |
| SCHEMBL173732 | 0.78 | GABRA1 (0.42) | GABRA1GABRB2ALDH1A1KDM4EHTR1A | |
| SCHEMBL3063776 | 0.78 | GABRA1 (0.42) | GABRA1GABRB2ALDH1A1KDM4EHTR1A | |
| SCHEMBL7394198 | 0.78 | GABRA1 (0.42) | GABRA1GABRB2ALDH1A1KDM4EHTR1A | |
| SCHEMBL2162474 | 0.78 | GABRA1 (0.42) | GABRA1GABRB2ALDH1A1KDM4ESLC6A2 | |
| SCHEMBL10561343 | 0.78 | GABRA1 (0.42) | GABRA1GABRB2ALDH1A1KDM4EHTR1A | |
| SCHEMBL173300 | 0.75 | GABRA1 (0.56) | GABRA1GABRB2ALDH1A1KDM4EHTR1A | |
| SCHEMBL29763626 | 0.75 | GABRA1 (0.56) | GABRA1GABRB2ALDH1A1KDM4EHTR1A | |
| SCHEMBL19437729 | 0.73 | GABRA1 (0.54) | GABRA1GABRB2ALDH1A1KDM4EHTR1A | |
| Phosphine SCHEMBL28908229 | 0.73 | GABRA1 (0.54) | GABRA1GABRB2ALDH1A1KDM4EHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230139240-A1 | RESIN COMPOSITION AND FILM | TOPPAN INC. (JP) | 2023-05-04 | — | — | US | disclosed |
| CN-110036214-A | Sealing device and sealing structure | NOK株式会社 | 2019-07-19 | — | — | CN | disclosed |
| US-9660118-B2 | Laminate for solar cell and solar cell module produced using same | DAI NIPPON PRINTING CO., LTD. (JP) | 2017-05-23 | — | — | US | disclosed |
| US-20140205226-A1 | ROLLING DEVICE | NSK LTD. (JP) | 2014-07-24 | — | — | US | disclosed |
| EP-2738241-A1 | ROLLING DEVICE | NSK Ltd. (JP) | 2014-06-04 | — | — | EP | disclosed |
| EP-2648227-A1 | LAMINATE FOR SOLAR CELL AND SOLAR CELL MODULE PRODUCED USING SAME | Mitsubishi Plastics, Inc. (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-20130247987-A1 | LAMINATE FOR SOLAR CELL AND SOLAR CELL MODULE PRODUCED USING SAME | MITSUBISHI PLASTICS, INC. (JP) | 2013-09-26 | — | — | US | disclosed |
| US-20090012013-A9 | Steroid modified solatrioses | LAWSON CHRISTOPHER J | 2009-01-08 | — | — | US | disclosed |
| US-20070135358-A1 | Steroid modified solatrioses | GLYCOMED SCIENCES LIMITED (KY) | 2007-06-14 | — | — | US | disclosed |
| EP-1644391-A2 | STEROID MODIFIED SOLATRIOSES | GlycoMed Sciences Limited (AU) | 2006-04-12 | — | — | EP | disclosed |
| WO-2005005449-A2 | STEROID MODIFIED SOLATRIOSES | GLYCOMED SCIENCES LIMITED (AU) | 2005-01-20 | — | — | WO | disclosed |
| EP-0647643-B1 | Bis(3,4-dialkylbenzylidene) sorbitol acetals and compositions containing same | MILLIKEN RES CORP (US) | 2002-03-13 | — | — | EP | disclosed |
| EP-0421634-B1 | Use of bis(3,4-dialkylbenzylidene) sorbitol acetals and of compositions containing it | MILLIKEN RES CORP (US) | 1995-08-16 | — | — | EP | disclosed |
| EP-0647643-A1 | Bis(3,4-dialkylbenzylidene) sorbitol acetals and compositions containing same | MILLIKEN RESEARCH CORPORATION (US) | 1995-04-12 | — | — | EP | disclosed |
| US-5135975-A | Plastic additives useful as nucleating agents for food or cosmetic containers or packaging | MILLIKEN RESEARCH CORPORATION (US) | 1992-08-04 | — | — | US | disclosed |
| US-5049605-A | Nucleation, food or cosmetic packaging | MILLIKEN RESEARCH CORPORATION (US) | 1991-09-17 | — | — | US | disclosed |
| EP-0421634-A2 | Use of bis(3,4-dialkylbenzylidene) sorbitol acetals and of compositions containing it | MILLIKEN RESEARCH CORPORATION (US) | 1991-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090012013-A9 | Steroid modified solatrioses | HSD17B7, CYP17A1, NR5A1 | GABRA1 569/4885GABRB2 948/4885ALDH1A1 2180/4885 |
| US-20070135358-A1 | Steroid modified solatrioses | HSD17B7, CYP17A1, NR5A1 | GABRA1 569/4885GABRB2 948/4885ALDH1A1 2180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.